GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Fluidigm Corporation (ADR) (FLDM) [hlAlert]

Rating:
Outperform
FLDM
down 21.02 %

Fluidigm Corporation (ADR) (FLDM) rated Outperform with price target $52 by Oppenheimer

Posted on: Monday,  Feb 3, 2014  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Fluidigm Corporation (ADR) (NASDAQ: FLDM) on 02/03/2014. Previously Oppenheimer rated Outperform Fluidigm Corporation (ADR) (NASDAQ: FLDM) on 10/05/2011.,
when the stock price was $14.41. Since then, Fluidigm Corporation (ADR) has lost 21.03% as of 01/22/2016's recent price of $11.38.
If you would have followed the previous Oppenheimer's recommendation on FLDM, you would have lost 21.02% of your investment in 1570 days.

Fluidigm Corporation (Fluidigm) develops, manufactures and markets integrated fluidic circuit systems. The Company?s microfluidic systems consist of instruments and consumables, including chips and reagents. It markets three microfluidic systems, including eight different commercial chips to pharmaceutical and biotechnology companies, academic institutions, diagnostic laboratories and Ag-Bio companies. As of December 31, 2010, Fluidigm had sold over 300 systems to customers in over 20 countries worldwide. As of December 31, 2010, it was developing products for use in molecular diagnostics and other markets. The Company sells three microfluidic systems, BioMark, EP1 and Access Array. All of its systems include chip controllers that control the activation of valves, loading of reagents, and recovery or wash steps within the chips. Each chip controller comes with software to control chip and instrument operations for particular applications.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/3/2014 8:25 AM Buy
None
45.70 52.00
as of 10/17/2014
1 Week up  16.04 %
1 Month down  -10.01 %
3 Months down  -5.77 %
1 YTD down  -33.12 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/5/2011 8:25 AM Buy
None
14.41 19.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy